세계의 광견병 진단 시장 규모 : 진단 방법별, 기술별, 지역별 범위 및 예측

Rabies Diagnostics Market Size And Forecast

Rabies Diagnostics Market size was valued at USD 1.9 Billion in 2024 and is projected to reach USD 3.8 Billion by 2031, growing at a CAGR of 4.9% from 2024 to 2031.

Global Rabies Diagnostics Market Drivers

The market drivers for the Rabies Diagnostics Market can be influenced by various factors. These may include:

Rising Rabies Incidence: In order to identify diseased animals and stop human transmission, rabies diagnostics are becoming more and more necessary, especially in areas where vaccination programmes are less common.

Government Regulations And Initiatives: Mandatory rabies vaccination programmes for wildlife and pets are examples of government-led rabies control measures that may increase demand for rabies diagnostics. Market conditions may also be impacted by laws governing the import and export of animals.

Technological Advancements: The accuracy, speed, and convenience of diagnosing rabies are improved by advances in diagnostic technologies, including as molecular diagnostics (PCR), next-generation sequencing, and quick immunodiagnostic testing. This expands the market.

Growing Pet Ownership: As the number of people owning pets rises around the world, there is a greater need for rabies diagnostics for dogs, cats, and other household animals.

Public awareness campaigns and education initiatives regarding the dangers of rabies transmission and the value of early diagnosis can be the main drivers of the need for rabies diagnostics.

Worldwide Travel And Tourism: As a result of the increased danger of rabies transmission across countries, areas with significant tourist influxes must have a strong diagnostic infrastructure.

Animal Welfare Concerns: As awareness of animal welfare and the morality of treating animals grows, so does the need for precise and compassionate rabies testing techniques, which encourages the use of cutting-edge diagnostic technologies.

Outbreak Preparedness: To swiftly detect and contain outbreaks, especially in areas vulnerable to epidemics, governments and healthcare institutions invest in rabies diagnostics as part of their preparedness plans.

Research And Development: By generating new opportunities and spurring innovation, ongoing research and development efforts targeted at providing innovative diagnostic methods, vaccinations, and therapies for rabies help to expand the diagnostics industry.

Partnerships And Collaborations: By pooling resources and expertise, partnerships and collaborations between government agencies, research centres, and diagnostic companies help to create and commercialise new diagnostic instruments and propel market expansion.

Global Rabies Diagnostics Market Restraints

Several factors can act as restraints or challenges for the Rabies Diagnostics Market. These may include:

Regulatory Obstacles: Tight rules and lengthy approval procedures for diagnostic testing may impede the expansion of the market. For businesses launching new diagnostics, regulatory compliance may pose a serious obstacle.

Limited Infrastructure And Awareness: In areas where rabies is endemic, there may be insufficient healthcare infrastructure to provide widespread testing or a lack of knowledge of the significance of diagnostics.

High Costs: The price of diagnostic testing can be unaffordable, particularly in environments with limited resources. This may make diagnostics more difficult to get, especially in places where prevalence rates are high.

Technological Restrictions: The sensitivity, specificity, or speed of detection of current diagnostic techniques may be limited. To overcome these constraints, technological innovations in diagnostics are required.

Geographic Distribution Of Rabies: Because rabies is more common in some areas of the world, there may be less market opportunity for diagnostics in places with lower incidence rates.

Competition From Alternative Methods: In resource-constrained environments where economical solutions are favoured, alternative methods for diagnosing rabies, such as clinical observation or laboratory confirmation through virus isolation, may compete with diagnostic testing.

Logistical Difficulties: Sample transportation from remote locations to diagnostic labs, cold chain management, and making sure testing and reporting are completed on time can all be logistically difficult, particularly in underserved or rural areas.

Opposition To Change: Because of long-standing procedures or a lack of experience with more recent techniques, healthcare systems and practitioners may be reluctant to embrace new diagnostic tools or procedures.

Economic Factors: Financial strains or downturns may result in lower expenditure on healthcare, which may have an impact on the uptake of diagnostic tests and the expansion of the market as a whole. The zoonotic nature of rabies refers to the fact that the disease can infect both humans and animals. The intricate relationship among environmental conditions, human health, and animal health might create special difficulties for diagnosing and treating rabies, necessitating a multidisciplinary approach.

Global Rabies Diagnostics Market Segmentation Analysis

The Global Rabies Diagnostics Market is Segmented on the basis of Diagnostic Method, Technology, And Geography.

Rabies Diagnostics Market, By Diagnostic Method

Fluorescent Antibody Test (FAT): This is the gold standard for rabies diagnosis, but it requires specialized equipment and trained personnel.

Immunohistochemical Test (IHC): Similar to FAT, IHC is a confirmatory test that can identify rabies virus antigens in tissue samples.

Amplification Methods: These tests, like Polymerase Chain Reaction (PCR), can detect the rabies virus's genetic material, offering high sensitivity and specificity.

Histologic Examination: This method involves examining brain tissue samples under a microscope for signs of rabies infection.

Serology Tests: These tests measure antibodies against the rabies virus in a person's blood, indicating past exposure or vaccination.

Rabies Diagnostics Market, By Technology

ELISA/Immunohistochemistry (ELISA/IHC): These are common techniques used in various diagnostic tests, including rabies. ELISA involves an antigen-antibody reaction, while IHC uses antibodies to locate specific antigens in tissue samples.

Chromatography Techniques: These techniques separate components of a mixture, which can be helpful in rabies diagnosis for isolating the virus.

PCR (Polymerase Chain Reaction): A powerful technique for amplifying specific DNA sequences, allowing for highly sensitive detection of the rabies virus.

Rabies Diagnostics Market, By Geography

North America: Market conditions and demand in the United States, Canada, and Mexico.

Europe: Analysis of the Rabies Diagnostics Market in European countries.

Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.

Middle East and Africa: Examining market dynamics in the Middle East and African regions.

Latin America: Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Rabies Diagnostics Market are:
• Bio-Rad Laboratories, Inc.
• Aviva Systems Biology Corporation
• Norgen Biotek Corp.
• Demeditec Diagnostics GmbH
• Creative Diagnostics
• Abbexa Ltd.
• MyBioSource.com
• Express Biotech International Inc.
• BioNote, Inc.
• Merck KGaA

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Rabies Diagnostics Market, By Diagnostic Method

• Fluorescent Antibody Test (FAT)
• Immunohistochemical Test (IHC)
• Amplification Methods
• Histologic Examination
• Serology Tests

5. Rabies Diagnostics Market, By Technology

• ELISA/Immunohistochemistry (ELISA/IHC)
• Chromatography Techniques
• PCR (Polymerase Chain Reaction)

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• Bio-Rad Laboratories, Inc.
• Aviva Systems Biology Corporation
• Norgen Biotek Corp.
• Demeditec Diagnostics GmbH
• Creative Diagnostics
• Abbexa Ltd.
• MyBioSource.com
• Express Biotech International Inc.
• BioNote, Inc.

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References